1-1 of 1
Andrew Belch, FRCPC
Close
Sort by
Journal Articles

Phase II Trial of Bortezomib in Mantle Cell Lymphoma.

Andrew Belch, FRCPC, C. Tom Kouroukis, Michael Crump, Laurie Sehn, Randy Gascoyne, Richard Klasa, Powers Jean, Elizabeth Eisenhauer
Journal: Blood
Blood (2004) 104 (11): 608.
https://doi.org/10.1182/blood.V104.11.608.608
Published: 2004